Hemab Therapeutics Holdings, Inc. (COAG) Stock Price History & Returns
Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)
How Hemab Therapeutics Holdings, Inc. (COAG) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $39.06 sits 50% of the way up a 52-week range of $23.00 to $55.42; 29.5% below the 52-week high; above its 50-day moving average of $36.94; above its 200-day average of $37.21; a beta of 1.85 means it has historically moved more than the market.
Total return
Price change over each trailing period, not annualised.
Monthly closing prices
The last 7 months, newest first. 3 of 6 months closed higher than the month before. Each figure is the last close in that month.
Hemab Therapeutics Holdings, Inc. (COAG) price history — frequently asked questions
How has Hemab Therapeutics Holdings, Inc. performed over the last year?
Hemab Therapeutics Holdings, Inc. (COAG) has risen 0.0% over the last twelve months, measured on price alone.
What is Hemab Therapeutics Holdings, Inc.'s five-year return?
Over five years the COAG share price has gained 0.0%, excluding dividends.
What is Hemab Therapeutics Holdings, Inc.'s 52-week range?
Over the last year Hemab Therapeutics Holdings, Inc. (COAG) has traded between $23.00 and $55.42.
Price returns of other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.